Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)

@article{Patil2012CellularDO,
  title={Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly($\beta$-L-Malic Acid)},
  author={Rameshwar Patil and Jos{\'e} Antonio Portilla-Arias and Hui Ding and Bindu Konda and Arthur Rekechenetskiy and Satoshi Inoue and Keith L. Black and Eggehard Holler and Julia Y. Ljubimova},
  journal={International Journal of Molecular Sciences},
  year={2012},
  volume={13},
  pages={11681 - 11693}
}
Doxorubicin (DOX) is currently used in cancer chemotherapy to treat many tumors and shows improved delivery, reduced toxicity and higher treatment efficacy when being part of nanoscale delivery systems. However, a major drawback remains its toxicity to healthy tissue and the development of multi-drug resistance during prolonged treatment. This is why in our work we aimed to improve DOX delivery and reduce the toxicity by chemical conjugation with a new nanoplatform based on polymalic acid. For… 

Figures and Tables from this paper

Co-delivery of doxorubicin and curcumin by polymeric micelles for improving antitumor efficacy on breast carcinoma
TLDR
M micellar co-delivery of Dox and Cur could synergistically potentiate antitumor effects on breast tumor.
Poly(malic acid) bearing Doxorubicin and N-Acetyl Galactosamine as a site-specific prodrug for targeting hepatocellular carcinoma
TLDR
The presence of the targeting moiety, NAcGal, thus improves the cellular toxicity of the Dox, and synthesized and characterized novel poly(malic acid) derivatives bearing Doxorubicin (Dox), Poly(ethylene glycol) (PEG) and/or N-Acetyl Galactosamine (NAcGal) for drug delivery.
Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
TLDR
Results indicate that this hyperbranched polymeric carrier shows promise as a cancer theranostic, demonstrating active targeting to tumor cells with the capability for simultaneous drug release.
A pH-Sensitive, Biobased Calcium Carbonate Aragonite Nanocrystal as a Novel Anticancer Delivery System
TLDR
In vitro chemosensitivity using MTT, modified neutral red/trypan blue assay, and LDH on MDA MB231 breast cancer cells revealed that CaCO3/DOX nanocrystals are more sensitive and gave a greater reduction in cell growth than free DOX.
Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells
TLDR
Chemical binding of DOX·HCl to the carboxyl group of PEG coating GNPs selectively delivers high amount of drug to tumour-affected tissue which leads to reducing the unwanted effects of the drug in the non-affected ones.
Tumor Targeted Delivery of an Anti‐Cancer Therapeutic: An In Vitro and In Vivo Evaluation
TLDR
This targeted formulation of Chelator Dp44mT showed an outstanding toxicity towards glioma cell lines and patient‐derived stem cells in vitro, with IC50 values less than 125 nM, and caused no significant death in healthy brain microvascular endothelial cells.
In Vitro Delivery and Controlled Release of Doxorubicin for Targeting Osteosarcoma Bone Cancer
TLDR
This study showed that the DOX-loaded CaCO3 nanocrystals have promising applications in delivery of anticancer drugs and pH sensitivity of the controlled release characteristics of the drug at normal physiological pH 7.4 was shown but when exposed pH 4.8 the corresponding 80% was released in 50 min.
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles.
TLDR
This protocol provides useful information regarding the preparation and characterization of drug-loaded micelles and thus will facilitate the research and development of novel micelle-based cancer nanomedicines.
...
...

References

SHOWING 1-10 OF 50 REFERENCES
Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)
TLDR
TMZ-polymer nanoconjugates entered the tumor cells by receptor-mediated endocytosis, effectively reduced cancer cell viability, and can potentially be used for targeted tumor treatment.
Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles
TLDR
Both in vitro and in vivo experiments suggest that the gelatinase-mediated nanoscale delivery system is promising for improvement of antitumor efficacy in various overexpressed gelatinase cancers.
HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
TLDR
The characterization of a novel, targeted, nanobiopolymeric conjugate based on biodegradable, nontoxic, and nonimmunogenic PMLA offers a preclinical proof of concept for use of the PMLA nanoplatform for combination cancer therapy.
Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
TLDR
The remarkable antitumor activity of dendrimer–DOX results from the ability of the d endrimer to favorably modulate the pharmacokinetics of attached DOX.
Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation
TLDR
In both protective and therapeutic regimes of drug administration, the in vivo anti-tumor activity of the conjugates containing DOX was enhanced with long-term survivors in comparison with much less effective free DOX or a classic P(N-(2-hydroxypropyl)methacrylamide)HPMA–DOX conjugate (already clinically tested).
Polymer genomics: shifting the gene and drug delivery paradigms.
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
TLDR
The first conjugates to combine endocrine therapy and chemotherapy, and markedly enhanced in vitro activity, are described, which encourage further development of such novel, polymer-based combination therapies.
...
...